References: The Triage^® NGAL Test

1. Supavekin S, et al. Differential gene expression following early renal ischemia-reperfusion. (2003) Kidney Int; 63: 1714–24
2. Mishra J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. (2003) J Am Soc Nephrol; 4: 2534–43
3. Devarajan P, et al. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery and novel therapeutics. (2003) Mol Genet Metab 2003; 80: 365–76
4. Gwira JA, et al. Expression of Ngal regulates epithelial morphogenesis in vitro. (2005) J Biol Chem; 280: 7875–82
5. Nikolas T, et al. Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase–Associated Lipocalin for Diagnosing Acute Kidney Injury. Ann Intern Med. 2008;148:810-819

Further References:

1. Dent C, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit. Care 2007;11:R127
2. Haase-Fielitz, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - A prospective cohort study (2009) Critical Care Med vol. 37, No.2 553-560
3. Zappitelli M, et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study Crit Care Med (2009) Vol. 11, No. 4
4. H. Bachorzewska-Gajewska, Malyszko J. et al. NGAL and cystatin C: Are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Int J Cardiol 127 (2008) 290-291 doi:10.1016/j.ijcard.2007.04.048